Literature DB >> 24649001

Systemic and local injections of lupeol inhibit tumor growth in a melanoma-bearing mouse model.

Makiko Nitta1, Kazuo Azuma1, Keishi Hata2, Saori Takahashi2, Kikumi Ogiwara3, Takeshi Tsuka1, Tomohiro Imagawa1, Inoru Yokoe1, Tomohiro Osaki1, Saburo Minami1, Yoshiharu Okamoto1.   

Abstract

Melanoma is the most aggressive type of skin cancer and it is procured from activated or genetically altered epidermal melanocytes. In the present study, the tumor-suppressive effects of systemic and local injections of lupeol, a triterpene extracted from Indian lettuce (Lactuca indica), in a melanoma-bearing mouse model were evaluated. Mice were injected once with lupeol or olive oil (solvent control) subcutaneously into the skin of the back or into the tumor tissue. Seven days after the injection, the tumor growth rates were calculated and the tumor tissues were collected. Immunohistochemical staining for Ki-67 and proliferating cell nuclear antigen (PCNA) were performed. The tumor growth rates in the lupeol-injected group were significantly decreased compared to those observed in the non-treated (NT) and solvent control groups. Lupeol also significantly decreased the areas positively stained for Ki-67 and PCNA in the tumor tissues compared to those in the NT and solvent control groups. The results of the present study demonstrated that systemic and local injections of lupeol suppress tumor growth and induce cell cycle arrest in a melanoma-bearing mouse model. These data suggest that lupeol may be effective as a novel therapeutic option for melanoma patients.

Entities:  

Keywords:  Ki-67; anticancer; lupeol; melanoma; proliferating cell nuclear antigen; systemic injection

Year:  2013        PMID: 24649001      PMCID: PMC3917038          DOI: 10.3892/br.2013.116

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  21 in total

Review 1.  Ki67 protein: the immaculate deception?

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  2002-01       Impact factor: 5.087

2.  Differentiation-inducing activity of lupeol, a lupane-type triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line.

Authors:  K Hata; K Ishikawa; K Hori; T Konishi
Journal:  Biol Pharm Bull       Date:  2000-08       Impact factor: 2.233

Review 3.  PCNA, the maestro of the replication fork.

Authors:  George-Lucian Moldovan; Boris Pfander; Stefan Jentsch
Journal:  Cell       Date:  2007-05-18       Impact factor: 41.582

4.  Anti-inflammatory activity of lupeol and lupeol linoleate in rats.

Authors:  T Geetha; P Varalakshmi
Journal:  J Ethnopharmacol       Date:  2001-06       Impact factor: 4.360

5.  Role of p38 MAPK in lupeol-induced B16 2F2 mouse melanoma cell differentiation.

Authors:  Keishi Hata; Kazuyuki Hori; Saori Takahashi
Journal:  J Biochem       Date:  2003-09       Impact factor: 3.387

Review 6.  Canine oral melanoma.

Authors:  Philip J Bergman
Journal:  Clin Tech Small Anim Pract       Date:  2007-05

Review 7.  Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Bonnie E Gould Rothberg; Michael B Bracken; David L Rimm
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

Review 8.  Issues in the epidemiology of melanoma.

Authors:  S Oliveria; S Dusza; M Berwick
Journal:  Expert Rev Anticancer Ther       Date:  2001-10       Impact factor: 4.512

Review 9.  Systematic review of medical treatment in melanoma: current status and future prospects.

Authors:  Claus Garbe; Thomas K Eigentler; Ulrich Keilholz; Axel Hauschild; John M Kirkwood
Journal:  Oncologist       Date:  2011-01-06

Review 10.  Current management and novel agents for malignant melanoma.

Authors:  Byung Lee; Nikhil Mukhi; Delong Liu
Journal:  J Hematol Oncol       Date:  2012-02-14       Impact factor: 17.388

View more
  9 in total

Review 1.  Targeting drivers of melanoma with synthetic small molecules and phytochemicals.

Authors:  Leah Ray Strickland; Harish Chandra Pal; Craig A Elmets; Farrukh Afaq
Journal:  Cancer Lett       Date:  2015-01-15       Impact factor: 8.679

2.  Clinical systemic lupeol administration for canine oral malignant melanoma.

Authors:  Inoru Yokoe; Kazuo Azuma; Keishi Hata; Toshiyuki Mukaiyama; Takahiro Goto; Takeshi Tsuka; Tomohiro Imagawa; Norihiko Itoh; Yusuke Murahata; Tomohiro Osaki; Saburo Minami; Yoshiharu Okamoto
Journal:  Mol Clin Oncol       Date:  2014-10-30

Review 3.  Treatment of Canine Oral Melanomas: A Critical Review of the Literature.

Authors:  Paolo Pazzi; Gerhard Steenkamp; Anouska J Rixon
Journal:  Vet Sci       Date:  2022-04-19

4.  Diindolylmethane and Lupeol Modulates Apoptosis and Cell Proliferation in N-Butyl-N-(4-Hydroxybutyl) Nitrosamine Initiated and Dimethylarsinic Acid Promoted rat Bladder Carcinogenesis.

Authors:  Bhoopathy Prabhu; Annamalai Sivakumar; Sivapatham Sundaresan
Journal:  Pathol Oncol Res       Date:  2016-04-18       Impact factor: 3.201

5.  Differentiation-inducing and anti-proliferative activities of lupeol on canine melanoma cells.

Authors:  Kikumi Ogihara; Yuko Naya; Yoshiharu Okamoto; Keishi Hata
Journal:  Springerplus       Date:  2014-10-25

6.  Oral Administration of Surface-Deacetylated Chitin Nanofibers and Chitosan Inhibit 5-Fluorouracil-Induced Intestinal Mucositis in Mice.

Authors:  Ryo Koizumi; Kazuo Azuma; Hironori Izawa; Minoru Morimoto; Kosuke Ochi; Takeshi Tsuka; Tomohiro Imagawa; Tomohiro Osaki; Norihiko Ito; Yoshiharu Okamoto; Hiroyuki Saimoto; Shinsuke Ifuku
Journal:  Int J Mol Sci       Date:  2017-01-27       Impact factor: 5.923

7.  Non-surgical treatment of canine oral malignant melanoma: A case study of the application of complementary alternative medicine.

Authors:  Hiroyasu Itoh; Toshiyuki Mukaiyama; Takahiro Goto; Keishi Hata; Kazuo Azuma; Takashi Tsuka; Tomohiro Osaki; Tomohiro Imagawa; Yoshiharu Okamoto
Journal:  Oncol Lett       Date:  2014-04-07       Impact factor: 2.967

8.  The Safety and Anti-Tumor Effects of Ozonated Water in Vivo.

Authors:  Kohei Kuroda; Kazuo Azuma; Takuro Mori; Kinya Kawamoto; Yusuke Murahata; Takeshi Tsuka; Tomohiro Osaki; Norihiko Ito; Tomohiro Imagawa; Fumio Itoh; Yoshiharu Okamoto
Journal:  Int J Mol Sci       Date:  2015-10-22       Impact factor: 5.923

9.  Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment.

Authors:  Kohei Kuroda; Masamiti Yamashita; Yusuke Murahata; Kazuo Azuma; Tomohiro Osaki; Takeshi Tsuka; Norihiko Ito; Tomohiro Imagawa; Yoshiharu Okamoto
Journal:  Exp Ther Med       Date:  2018-07-06       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.